First case report of Rett syndrome in the Azeri Turkish population and brief review of the literature

Epilepsy & Behavior Case Reports
Jalal GharesouranLeila Vahedi

Abstract

Rett syndrome is a dominant X-linked male-lethal disorder largely caused by mutations in the gene encoding methyl-CpG binding protein 2 (MECP2). Clinical manifestations include neurodevelopmental disorder characterized by early-onset intractable seizures, severe developmental delay, intellectual disability, and abnormal electroencephalograms. Afflicted females show normal development until the age of 6 to 18 months, followed by gradual loss of speech abilities, microcephaly, social impairment, ataxia, and stereotypic hand movements. We report a 7-year-old girl who was born of a nonconsanguineous marriage presenting with mental retardation and delayed development. Physical examination revealed loss of speech, repetitive hand-wringing movement, short stature (120 cm), strabismus, microcephaly, and autistic behavior. The diagnosis was confirmed by sequencing MECP2 gene with heterozygous mutation C385A in exon 2. The current study aimed to report the first case of Rett syndrome in the Azeri Turkish population.

References

Jan 1, 1986·American Journal of Medical Genetics. Supplement·B Hagberg, I Witt-Engerström
Jan 1, 1985·Brain & Development·B HagbergJ Wilson
Mar 21, 2000·Mammalian Genome : Official Journal of the International Mammalian Genome Society·K ReichwaldP Kioschis
May 18, 2000·Human Molecular Genetics·P HuppkeF Hanefeld
May 18, 2000·Human Molecular Genetics·T BienvenuJ Chelly
Jun 28, 2001·JAMA : the Journal of the American Medical Association·S Chakrabarti, E Fombonne
Mar 27, 2002·Journal of Child Neurology·Jong Hee ChaeKi Joong Kim
Apr 11, 2007·Arquivos de neuro-psiquiatria·Andrea StachonSalmo Raskin
Feb 13, 2008·Epilepsia·Nadia Bahi-BuissonThierry Bienvenu
Sep 16, 2008·Brain : a Journal of Neurology·Nadia Bahi-BuissonThierry Bienvenu
Dec 5, 2009·Genes, Brain, and Behavior·B De FilippisG Laviola

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.